Lihuayi Weiyuan Chemical Co., Ltd. (SHA:600955)
China · Delayed Price · Currency is CNY 11.65
-0.07 (-0.60%)
Nov 13, 2026, 3:00 PM CST
Lihuayi Weiyuan Chemical Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 10,635 | 8,753 | 9,507 | 7,037 | 7,790 | 9,611 |
Other Revenue | 15.47 | 15.47 | 15.23 | 13 | 8.22 | 23.59 |
| 10,651 | 8,768 | 9,522 | 7,050 | 7,798 | 9,635 | |
Revenue Growth | 17.55% | -7.92% | 35.06% | -9.59% | -19.06% | 119.65% |
Cost of Revenue | 10,635 | 8,960 | 9,430 | 6,836 | 6,994 | 6,649 |
Gross Profit | 15.36 | -191.32 | 91.97 | 214.11 | 803.68 | 2,985 |
Selling, General & Admin | 46.54 | 89.7 | 101.31 | 111.61 | 89.98 | 76.22 |
Research & Development | 38.58 | 35.92 | 36.8 | 31.11 | 28.06 | 15.47 |
Other Operating Expenses | -9.89 | -26.5 | -101.43 | 12.99 | 20.4 | 53.82 |
Operating Expenses | 75.08 | 99.15 | 33.79 | 158.67 | 138.44 | 145.51 |
Operating Income | -59.71 | -290.47 | 58.17 | 55.44 | 665.24 | 2,840 |
Interest Expense | -56.35 | -106.4 | -34.77 | -8.97 | -6.38 | -21.56 |
Interest & Investment Income | 13.54 | 11.2 | 22.04 | 39.45 | 108.37 | 20.16 |
Currency Exchange Gain (Loss) | 0.23 | 0.23 | -0.44 | 0.85 | -1.35 | 0.06 |
Other Non Operating Income (Expenses) | -133.82 | -0.95 | -0.68 | -0.65 | -0.61 | -0.8 |
EBT Excluding Unusual Items | -236.11 | -386.39 | 44.32 | 86.12 | 765.28 | 2,838 |
Gain (Loss) on Sale of Investments | 0.62 | - | 0.21 | 0.13 | 2.63 | 13.77 |
Gain (Loss) on Sale of Assets | -71.89 | -82.67 | -1.15 | -0.94 | -5.49 | -1.93 |
Asset Writedown | -780.16 | -721.01 | - | - | -6.53 | -0.77 |
Other Unusual Items | 20.06 | 14.12 | 13.69 | 19.06 | 32.23 | 9.54 |
Pretax Income | -1,067 | -1,175 | 57.07 | 104.42 | 788.29 | 2,858 |
Income Tax Expense | -176.35 | -183.89 | 0.48 | 5.8 | 180.51 | 708.55 |
Net Income | -890.62 | -991.56 | 56.59 | 98.62 | 607.77 | 2,150 |
Net Income to Common | -890.62 | -991.56 | 56.59 | 98.62 | 607.77 | 2,150 |
Net Income Growth | - | - | -42.62% | -83.77% | -71.73% | 200.61% |
Shares Outstanding (Basic) | 560 | 548 | 566 | 548 | 548 | 455 |
Shares Outstanding (Diluted) | 560 | 548 | 566 | 548 | 548 | 455 |
Shares Change | -0.23% | -3.19% | 3.29% | 0.06% | 20.22% | 10.18% |
EPS (Basic) | -1.59 | -1.81 | 0.10 | 0.18 | 1.11 | 4.72 |
EPS (Diluted) | -1.59 | -1.81 | 0.10 | 0.18 | 1.11 | 4.72 |
EPS Growth | - | - | -44.44% | -83.78% | -76.48% | 172.83% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 193.17 | -10.56 | -550.92 | -3,769 | -1,958 | 1,710 |
Free Cash Flow Per Share | 0.34 | -0.02 | -0.97 | -6.88 | -3.58 | 3.75 |
Dividend Per Share | 0.050 | 0.050 | 0.030 | 0.055 | 0.166 | 0.391 |
Dividend Growth | 66.67% | 66.67% | -45.45% | -66.87% | -57.55% | - |
Gross Margin | 0.14% | -2.18% | 0.97% | 3.04% | 10.31% | 30.99% |
Operating Margin | -0.56% | -3.31% | 0.61% | 0.79% | 8.53% | 29.47% |
Profit Margin | -8.36% | -11.31% | 0.59% | 1.40% | 7.79% | 22.31% |
Free Cash Flow Margin | 1.81% | -0.12% | -5.79% | -53.46% | -25.10% | 17.75% |
EBITDA | 1,094 | 691.06 | 810.32 | 504.34 | 1,078 | 3,237 |
EBITDA Margin | 10.27% | 7.88% | 8.51% | 7.15% | 13.83% | 33.59% |
D&A For EBITDA | 1,154 | 981.53 | 752.15 | 448.9 | 413.25 | 396.91 |
EBIT | -59.71 | -290.47 | 58.17 | 55.44 | 665.24 | 2,840 |
EBIT Margin | -0.56% | -3.31% | 0.61% | 0.79% | 8.53% | 29.47% |
Effective Tax Rate | - | - | 0.84% | 5.56% | 22.90% | 24.79% |
Revenue as Reported | 2,016 | 8,768 | 9,522 | 7,050 | 7,798 | 9,635 |